The global high level disinfection services market size was valued at USD 22.39 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.30% from 2022 to 2030. The demand for high level disinfection services is increasing owing to the surge in Hospital-acquired Infections (HAIs), rising incidence of infectious diseases, and increasing number of surgical procedures across the globe. HAIs are nosocomial infections that are more frequent in people undergoing long-term care, most notably surgical treatment. HAIs are most common in the elderly, infants, and patients with weakened immune systems.
A variety of causes, including a lack of proper hygiene in healthcare facilities, the use of catheters, and an overuse of antibiotics, might surge susceptibility to HAIs. These types of diseases may often lead to central line-related bloodstream infections, surgical site infections, Urinary Tract Infections (UTIs) associated with catheters, ventilators, hospital-acquired pneumonia, and infections associated with Clostridium difficile.
The most common HAIs are:
Central line-associated bloodstream infections
Methicillin-resistant Staphyloccocus aureus (MRSA)
Vancomycin-resistant Enterococci bloodstream infections
Surgical site infections (SSIs)
An increase in the prevalence of HAIs due to a lack of sanitation and preventive measures is a major factor expected to propel the growth of the market for high-level disinfection services during the forecast period. According to a research article published in British Medical Journal, in 2016-2017, there were about 6,53,000 healthcare-associated infections (HCAIs) reported among 13.8 million adult inpatients in NHS hospitals in England. Of these, around 22800 patients died due to infection. Also, CDC states that about 1 in 31 hospital patients has at least 1 healthcare-associated infection per day.
The incidence of HAIs depends largely on the patient's immunity, the practices of infection prevention and hygiene, and the presence of different infectious agents in the healthcare facility, leading to an upsurge in demand for infection control services. Hand hygiene with antiseptics and low-level disinfectants, and sterilization of gastro-intestinal endoscopes with potent, high-level disinfectants are both possible preventive measures.
The continuous product launches by key players operating in the market for high-level disinfection services are one of the major factors contributing to market growth during the forecast period. For instance, in March 2020, specialty chemicals company LANXESS launched the high-level disinfectant Rely+On Virkon, which is highly effective against the coronavirus. Tests have confirmed that Rely+On Virkon inactivates a closely related substitute of the rapidly spreading corona strain. Furthermore, Solvay also offers peracetic acid (PAA) based liquid solution, PROXITANE that is effective against wide-ranging fungi, bacteria, and viruses, including SAR-CoV-2, on clean and soiled surfaces.
In the US, PROXITANE AHC has been granted approval for use against SARS-CoV-2 by the US Environmental Protection Agency (EPA Registration Number 68660-11).
In Europe, PROXITANE solutions have been tested and proven effective against a wide range of viruses, including SARS-CoV-2, aiding a log 4 reduction of these viruses at tremendously low PAA concentration (0.3%), according to standard EN14476:2013. Testing exhibited efficacy in both clean and dirty conditions.
In Brazil, PROXITANE solution is available as a high-level surface disinfectant for hospitals.
The rising prevalence of chronic diseases such as diabetes, cancer, and other autoimmune diseases is expected to drive demand for high-level disinfectant services. Antimicrobial tolerance, rising adoption of unhealthy and sedentary lifestyles, obesity, and alcohol intake are all significant contributors to the rising prevalence of chronic diseases. According to the World Health Organization (WHO), chronic disease prevalence has been expected to surge by 57.00% by the year 2020.
Moreover, the rising geriatric population across the globe is the primary demographic suffering from chronic diseases. The WHO states that, by 2050, the world’s population aged 60 years and older is expected to total 2 billion. As a result, the increasing prevalence of chronic diseases has dramatically raised hospital admission rates. Blankets, clean fluids, and appliances are some of the necessities in hospitals and other care services. Thus, in such situations, high-level disinfectants and the environment efficiently serve the purpose, as they mitigate the risk of infection transmission among patients and increase care quality. Thus, the increasing prevalence of chronic diseases is projected to have a positive effect on the market during the projection period.
Additionally, rising endoscopic procedures globally are expected to boost the demand for high-level disinfection services. For instance, a survey conducted by the NCBI, from April 2020 to May 2020, found that around 2,069,447 endoscopic procedures were performed in a year. Similarly, according to the University College London in April 2019, 110,584 endoscopic procedures were conducted. Endoscopic devices require major quality assurance for disinfection, and hence high-level disinfection services are used to disinfect these contaminated endoscopes, thereby impelling the market further.
Furthermore, the outbreak of the COVID-19 pandemic had a positive impact on the high-level disinfection services market. For instance, as per the American Chemical Society, COVID-19 has increased the use of disinfectants worldwide. Regular disinfection of hospital equipment such as endoscopes to curb the spread of COVID-19 helped the high-level disinfection services market to advance. Additionally, to cope with the rising demand, many key market players underwent strategic alliances such as mergers, acquisitions, partnerships, and geographic expansions. For instance, in February 2021, STERIS plc completed the acquisition of Cantel Medical. This acquisition was expected to help the company tackle the increasing demand for high-level disinfection services, thereby boosting the high-level disinfection services market during the COVID-19 period.
The outsourcing segment dominated the high-level disinfection services market and held the largest revenue share of 59.69% in 2021. The segment is expected to witness a considerable growth rate during the forecast period. Hospitals and clinical diagnostics centers usually prefer outsourcing disinfection services. Several benefits are associated with outsourcing such as cost-saving, customized cleaning services, and usage of advanced technology. Furthermore, advances in global healthcare practices have resulted in hospitals outsourcing disinfection and sterilization services. This has provided new opportunities for manufacturers of HLD equipment.
Outsourcing facilities are more prevalent in developed economies and are gradually infiltrating developing economies. In countries like the U.S. and a few countries in Western Europe, healthcare facilities are increasingly outsourcing Central Sterile Supply Department (CSSD) nations to meet infection control standards as well as top-quality management of complex surgical instruments. Several experts suggest that the third-party sterilization and disinfection vendors will increase their focus on becoming end-to-end solution providers to cover cleaning, sterilization, tracking and managing workflow, CSSD layout design, and logistics services. This will drive Original Equipment Manufacturers (OEMs) to embrace value-added services including inventory management, CSSD integration, and equipment repair in their portfolio over the traditional services-centered approach. This step would ensure third-party sterilization services are in direct contact with key decision-makers for better infection control by opening further avenues for market expansion.
The in-house segment is anticipated to expand at a considerable CAGR of 6.95% in the market for high-level disinfection services during the forecast period. In-house disinfection provides complete control over service movement and eliminates the extra handling and charges associated with shipping loads to and from the facility. However, in-house disinfection is only feasible if there is enough volume to keep the disinfection facility running at or near capacity. Moreover, it is costlier as compared to outsourcing. Outsourcing has several advantages over in-house services, thus the latter segment will experience sluggish growth in the forecast period.
The glutaraldehyde segment dominated the market for high-level disinfection services and held the largest revenue share of 22.50% in 2021. The segment is anticipated to witness a considerable growth rate during the projection period. Aldehyde disinfectants are often used for endoscopic procedures and surgical unit reprocessing. Glutaraldehyde has long and widely been used as an HLD for reusable surgical equipment in healthcare facilities. The growing number of surgical procedures across the globe is expected to fuel demand for these services. Furthermore, hospital-acquired infections caused by excessive surgical unit reprocessing are expected to fuel demand for these solutions, causing the segment to rise profitably during the forecast years.
The hydrogen peroxide segment is anticipated to witness a considerable growth rate of a CAGR of 7.53% during the assessment period. The US Food and Drug Administration has authorized disinfectant solutions containing 7.5% hydrogen peroxide for sterilization and high-level disinfection in healthcare settings. Hydrogen peroxide is the disinfectant of choice for semi-critical and non-critical devices, as well as a suitable surface disinfectant, due to its broad-spectrum bactericidal, sporicidal, virucidal, and fungicidal properties. Hydrogen peroxide disinfectant solutions are considered ideal substitutes for toxic sterilants, such as ethylene oxide and aldehyde disinfectants. Thereby, owing to the aforementioned advantages, the segment is expected to grow at a rapid pace.
The hospitals and clinics segment dominated the market for high-level disinfection services and held the largest revenue share of 38.70% in 2021. The segment is expected to witness a considerable growth rate during the forecast period. The rising prevalence of hospital-acquired infections is generating high demand for HLD in hospitals and other healthcare settings. Moreover, in several nations, the COVID-19 pandemic brought the use of hospital high-level disinfectant services to the mainstream, as part of bundled strategies to control the virus.
Furthermore, the increased number of surgical procedures, stringent safety guidelines for both staff and patients, and medical waste disposal are driving the adoption of disinfection services in hospitals. However, according to a survey by the Joint Commission in 2018, more than 50.00% of hospitals were noncompliant with high-level disinfection and sterilization standard IC.02.02.01, EP2. Understanding the severity associated with HAIs, coronavirus infections, and several other infections, more hospitals should be compliant with HLD standards.
Moreover, to maintain a healthy environment in clinics, proper hygiene and sanitation are needed. The spread of COVID-19 necessitates the implementation of preventive measures to limit the disease's spread; as a result, clinics are taking preventive measures. These factors are expected to fuel the segment's growth in the forecast period by encouraging clinics to use high-level disinfection services.
The diagnostic laboratories segment is projected to advance at a growth rate of 7.32% during the forecast period. The need for optimal sterility and precision in testing procedures has led to increased demand for disinfection equipment in diagnostic laboratories and research centers.
Majorly due to rising infectious diseases, the number of people undertaking various tests has surged. This situation has created a burden on diagnostic and pathology laboratories that necessitates the use of HLD solutions. These are commonly used in research laboratories to clean medical equipment and testing kits.
In addition, the dissection of infected medical instruments after use is an essential aspect of research centers' safety procedures in order to curb false results. The FDA has set guidelines to review the safety and sterility practices in research labs, which is expected to boost segment growth.
North America dominated the high-level disinfection services market and accounted for the largest revenue share of 35.55% in 2021. North America is projected to lead the high-level disinfectant services industry, owing to the outbreak of COVID-19 in this area which has significantly increased demand for surface disinfectants.
The Environmental Protection Agency (EPA) of the United States released an updated list of EPA-registered disinfectant services that have been qualified for use against SARS-CoV-2 in March 2020, which included approximately 200 additional services and 40 new services.
Government initiatives such as awareness campaigns and discharge surveys can help combat HAIs; the Department of Health and Human Services in the US announced the Collaboration for Patients initiative to reduce HAIs. It focuses on life-threatening HAIs such as catheter-associated urinary tract infections, bloodstream infections, SSIs, and ventilator-associated pneumonia.
Furthermore, the number of surgeries in the region has risen dramatically in recent years. According to the ASPS (American Society of Plastic Surgeons), more than 17.7 million surgical and minimally invasive aesthetic operations were performed in the US in 2018. As a result of both of these factors, North America is projected to have the highest revenue share in the market during the forecast period.
In Asia Pacific, the market for high-level disinfection services is anticipated to witness the fastest growth rate of 7.59% during the assessment period, due to the growing cases of infection-transmitted diseases, such as COVID-19, exponentially in India, which are surging the demand for surface disinfectants. According to statistics provided by the Word Health Organization, as of July 29, 2022, India logged a record 44 million COVID-19 patients, leading to around 5,26,000 deaths.
Moreover, a significant increase in the geriatric population susceptible to hospital-acquired infections is expected to propel regional market growth. According to the UNFPA statistics, the number of older people in Asia Pacific will triple, reaching 1.3 billion by 2050. Additionally, the rising incidence of chronic diseases, rising number of surgeries, increasing prevalence of surgical site infections, and HAIs will contribute to the rising demand for HLD services leading to regional market growth.
Key players are involved in adopting strategies such as mergers and acquisitions, partnerships, and launching new services to strengthen their foothold in the market.
In July 2020, oneSOURCE collaborated with Pfiedler Education, a subsidiary of the Association of periOperative Registered Nurses (AORN Inc.), to provide free access to a webinar course from sterile processing expert Rose Seavey. The course focused on effective tools to help pass accreditation surveys and enable healthcare professionals to receive continuing education in high-level disinfection, sterilization, and implants and tissue management
In June 2019, CS Medical launched TEEClean, an automated TEE probe cleaner disinfector. TEEZyme, an enzymatic solution that is injected into the cleaning and disinfection reservoir after a soiled TEE probe has been properly inserted, is used in TEEClean. It is used in high-level disinfection.
Some prominent players in the global high-level disinfection services market include:
Fortive Corporation (ASP)
Metrex Research, LLC
Rentokil Initial plc
Market size value in 2022
USD 23.97 billion
Revenue forecast in 2030
USD 42.12 billion
CAGR of 7.30% from 2022 to 2030
Base year for estimation
2018 - 2020
2022 - 2030
Revenue in USD million and CAGR from 2022 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Services, compound, end-use, region
North America; Europe; Asia Pacific; Latin America; Middle East & Africa (MEA)
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Sweden; Russia; Japan; China; India; South Korea; Australia; ASEAN; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Israel; Egypt; Nigeria; GCC countries
Key companies profiled
ECOLAB; GE Healthcare; Altapure; OLYMPUS CORPORATION; Getinge AB; Fortive Corporation (ASP); Lifemed; Steelco; Steris PLC; Microchem Laboratory; Metrex Research, LLC; EcoFMR.com; Jani-King; Rentokil Initial plc
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global high-level disinfection services market report based on services, compound, end-use, and region:
Services Outlook (Revenue, USD Million, 2018 - 2030)
Compound Outlook (Revenue, USD Million, 2018 - 2030)
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Academic and Research Institutes
Regional Outlook (Revenue, USD Million, 2018 - 2030)
Middle East & Africa
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B